Subjective distress mediates the association between olfactory dysfunction duration and depression in post COVID 19 patients
- PMID: 40594614
- PMCID: PMC12218131
- DOI: 10.1038/s41598-025-07953-z
Subjective distress mediates the association between olfactory dysfunction duration and depression in post COVID 19 patients
Abstract
Olfactory dysfunction (OD) has been reported in individuals who recovered from COVID-19. Those with OD after COVID-19 (COVID-19 group) exhibited more severe psychiatric symptoms than those with OD from other etiologies (non-COVID-19 group). This study investigates differences in psychological symptoms and related clinical factors between these groups. Fifty-two participants (COVID-19 group: 26; non-COVID-19 group: 26) were recruited. Both objective and subjective olfactory function were assessed, and symptoms of depression, anxiety, and perceived stress were measured using self-reported scales. There were no significant differences in objective and subjective olfactory function or psychological symptoms between the groups, except for age and the short version of the Questionnaire of Olfactory Disorders-negative statements (sQOD-NS). The sQOD-NS score was negatively correlated with OD duration only in the COVID-19 group. In both groups, the sQOD-NS was significantly correlated with Patient Health Questionnaire-9 (PHQ-9) scores. Mediation analysis showed that OD duration indirectly affected PHQ-9 scores via the sQOD-NS in the entire sample, particularly in the COVID-19 group. These findings suggest that subjective distress from OD may mediate the relationship between OD duration and depressive symptoms in COVID-19 patients, highlighting the need for targeted psychiatric interventions after recovery from COVID-19.
Keywords: Anxiety disorders; COVID-19; Depressive disorder; Olfaction disorders; Psychological distress.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Specialist breast care nurses for support of women with breast cancer.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD005634. doi: 10.1002/14651858.CD005634.pub3. Cochrane Database Syst Rev. 2021. PMID: 34559420 Free PMC article.
-
Psychological therapies for treatment-resistant depression in adults.Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2. Cochrane Database Syst Rev. 2018. PMID: 29761488 Free PMC article.
-
Psychological and/or educational interventions for the prevention of depression in children and adolescents.Cochrane Database Syst Rev. 2004;(1):CD003380. doi: 10.1002/14651858.CD003380.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003380. doi: 10.1002/14651858.CD003380.pub3. PMID: 14974014 Updated.
-
Platelet-Rich Plasma for Treating COVID-19-Related Anosmia, Hyposmia, and Parosmia: A Controlled Longitudinal Study.Otolaryngol Head Neck Surg. 2025 Apr;172(4):1450-1458. doi: 10.1002/ohn.1149. Epub 2025 Jan 31. Otolaryngol Head Neck Surg. 2025. PMID: 39888025 Clinical Trial.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Nordin, S. & Bramerson, A. Complaints of olfactory disorders: epidemiology, assessment and clinical implications. Curr. Opin. Allergy Clin. Immunol.8, 10–15. 10.1097/ACI.0b013e3282f3f473 (2008). - PubMed
-
- Mori, J. et al. Clinical study of olfactory disturbance. Acta Otolaryngol. Suppl.538, 197–201 (1998). - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous